The pharmaceuticals lobby shored up its campaign against increasing use of the 340B Drug Discount Program with a new analysis estimating its broader use pulled $6.5 billion in rebates away from the ...

The pharmaceutical lobby is ramping up its opposition to nonprofit health systems’ expanding use of the 340B Drug Discount program with the launch of an advertising campaign describing the subsidies ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The nation's top pharmaceutical ...

As pharma companies face an imminent deadline from President Donald Trump related to his "Most Favored Nation" (MFN) drug pricing demands, the industry's top U.S. lobbying group is touting three ...

Sept 29 (Reuters) - U.S. pharmaceutical lobby group PhRMA said on Monday it would launch a new website in January to help patients buy prescription drugs directly from manufacturers, bypassing ...

A powerful group of conservative interest groups and activists penned a letter last week to Republican congressional leaders asking them to rein in a program that provides discounted outpatient drugs ...

A major consumer advocacy organization began consistently criticizing foes of pharmaceutical manufacturers after the industry’s top trade association directed large donations its way, a Washington ...

Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the Pharmalot campus, where we have cool breezes and sunny skies greeting us. Who could ask for ...